Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subacromial Corticosteroid Injection + Exercise in Supraspinatus Tendinopathy
NCT07880522Active, not recruiting
- Start
- Aug 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial in supraspinatus tendinopathy comparing Subacromial Corticosteroid Injection + Exercise with Placebo Injection + Exercise (2 arms). Primary endpoint: Change in Supraspinatus Tendon Elasticity Measured by Shear Wave Elastography at Week 12. Started Aug 2026; status: active, not recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
supraspinatus tendinopathy
Beyond the preview
Go deeper on NCT07880522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07880522.